Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC EPI-001 227947-06-0 200mg
SDP

Catalog No. 5000092736
Encompass_Preferred

EPI-001 (CAS 227947-06-0) is a small-molecule inhibitor targeting the amino-terminal domain (NTD) of the androgen receptor (AR) It is designed to inhibit AR transcriptional activation by disrupting protein-protein interactions essential for AR function thus regulating AR-dependent signaling pathways EPI-001 exerts its biological activity primarily through inhibition of the AR NTD transactivation In cell-based studies EPI-001 demonstrates suppression of AR-mediated transcriptional activation with an IC50 value of approximately 6 M Based on these pharmacological properties EPI-001 holds research potential in prostate cancer particularly in castration-resistant prostate cancer models

Catalog No. 50-000-92736 Supplier Apexbio Technology LLC Supplier No. B6041200
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EPI-001 (CAS 227947-06-0) is a small-molecule inhibitor targeting the amino-terminal domain (NTD) of the androgen receptor (AR) It is designed to inhibit AR transcriptional activation by disrupting protein-protein interactions essential for AR function thus regulating AR-dependent signaling pathways EPI-001 exerts its biological activity primarily through inhibition of the AR NTD transactivation In cell-based studies EPI-001 demonstrates suppression of AR-mediated transcriptional activation with an IC50 value of approximately 6 M Based on these pharmacological properties EPI-001 holds research potential in prostate cancer particularly in castration-resistant prostate cancer models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.